Jiryeon Jang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

CDH1 mutations in gastric cancers are not associated with family history.

CDH1 mutations in gastric cancers are not associated with family history.

Journal: Pathology, research and practice
Published: January 20, 2020

Dysregulated miRNA in a cancer-prone environment: A study of gastric non-neoplastic mucosa.

Dysregulated miRNA in a cancer-prone environment: A study of gastric non-neoplastic mucosa.

Journal: Scientific reports
Published: November 28, 2019

PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation.

PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation.

Journal: Virchows Archiv : an international journal of pathology
Published: July 04, 2019

Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells.

Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells.

Journal: Molecular biology reports
Published: December 06, 2018

MicroRNA Expression Profiles in Gastric Carcinogenesis.

MicroRNA Expression Profiles in Gastric Carcinogenesis.

Journal: Scientific reports
Published: December 08, 2017

Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2-Amplified Gastric Cancer Patient-Derived Cell Model.

Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2-Amplified Gastric Cancer Patient-Derived Cell Model.

Journal: Translational oncology
Published: January 02, 2017

Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell Carcinoma.

Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell Carcinoma.

Journal: Translational oncology
Published: November 13, 2016

Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion.

Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion.

Journal: Oncotarget
Published: October 17, 2016

BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells.

BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells.

Journal: Translational oncology
Published: January 14, 2016

Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing.

Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing.

Journal: Translational oncology
Published: October 22, 2015

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment.

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment.

Journal: Oncotarget
Published: October 14, 2015

NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line.

NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line.

Journal: Oncotarget
Published: June 22, 2015
Showing 1-12 of 28

Last Updated: 09/26/2026